Event Details I December 22th, 2025 Recorded VDO I December 22th, 2025 Event Details I December 22th, 2025 You are invited to an exciting hybrid seminar presented by the...
📢 ATTENTION Immunotherapy Researchers & Oncologists! The clock is ticking! Join TTCI at the WIC-APAC 2026 Conference in Taipei, Taiwan. This is the must-attend event for the latest in...
Join Us: Medical Applications of Gene Editing and Synthetic Biology Technologies The Siriraj Center of Excellence for Cancer Immunotherapy (SiCORE-CIT), in collaboration with The Genetics Society of Thailand, the...
Research Topics Antitumor activities of chimeric antigen receptor T cells targeting Mucin-1 with self-released anti-PD-1 IgG antibody Researchers Nattarika Khuisangeam Institute Medical Microbiology Interdisciplinary and International Program, Graduate School,...
Registration Open – 1st International Scientific Symposium in Hematologic Malignancy The Center of Excellence in Translational Hematology (CETH), Faculty of Medicine, Chulalongkorn University, is pleased to announce the 1st...
Research Topics A multi-center clinical research project to study the Safety and Efficacy of CD19 CAR T-cells in ALL (Acute Lymphoblastic Leukemia) by Academic Hubs Researchers Koramit Suppipat and...
Research Topics Development of CAR T-cell Products for the Treatment of Hematologic Malignancies to Enhance the Competitiveness of Thailand’s Advanced Therapy Medicinal Products (ATMP) Industry (Phase 1) Researchers Koramit...
Research Topics Clinical research project on CAR T-cells in collaboration with a multi-institutional network (Academic CAR T-cell network). Researchers Koramit Suppipat and TTCI team Institute Faculty of Medicine, Chulalongkorn...
Research Topics Safety/Phase I study of PiggyBac transposon mediated Chimeric Antigen Receptor T cells targeting CD-19 in Thai patients with refractory systemic lupus Erythematosus Researchers Wannagam Kijthanamongkolchai Institute Faculty...
Research Topics Expanding Horizons in Immunotherapy: Integrating Advanced Cell Engineering, Reprogramming, and Adjunct Therapies for Cancer and inflammatory-mediated diseases Researchers Prof.Nattiya Hirankarn and TTCI team Institute Faculty of Medicine,...